Form 4: Akamai CTO Sells 3,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Akamai Technologies' Chief Technology Officer, Robert Blumofe, sold 3,000 shares of common stock for $77 per share, executed under a pre-arranged 10b5-1 plan.
Summary
- Robert Blumofe, Chief Technology Officer of Akamai Technologies Inc. (AKAM), reported a sale of common stock.
- The transaction involved the disposition of 3,000 shares of common stock on August 22, 2025.
- The shares were sold at a price of $77 per share.
- This sale was conducted pursuant to a Rule 10b5-1 trading plan, which Dr. Blumofe adopted on March 12, 2025.
- Following the reported transaction, Mr. Blumofe directly beneficially owns 27,910 shares of common stock.
- Additionally, Mr. Blumofe indirectly beneficially owns 64.184 shares through a 401(k) Plan, as of August 21, 2025.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of an insider stock sale executed under a pre-arranged 10b5-1 plan, which is a common practice for corporate executives to manage their stock holdings and is not inherently positive or negative for the company's prospects.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing, as it is solely a disclosure of an insider transaction.
Industry Context
This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive landscape analysis.
Stakeholder Impact
- Shareholders: Disclosure of insider trading activity provides transparency regarding executive stock ownership changes, which can inform investment decisions.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Rule 10b5-1 Plan adopted by Dr. Blumofe. |
| 08/21/2025 | Date for calculation of indirect beneficial ownership via 401(k) Plan. |
| 08/22/2025 | Date of common stock transaction (sale) and filing date of Form 4. |
Recommendation
holdThe filing reports a routine insider sale by the CTO under a pre-arranged 10b5-1 plan. Such sales are common for executives for personal financial planning and do not typically signal a change in company fundamentals or outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Akamai Technologies, AKAM, Robert Blumofe, CTO, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.